Product Detail
N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 (Impurity)
Impurity
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Impurity
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 (Impurity) Product Information
N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 (Impurity) is listed under Impurity. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96981.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 (Impurity)
CAS No.
-
CAT No.
CS-T-96981
Molecular Formula
C14H17D3N2O3
Molecular Weight
267.34
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 (Impurity)
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 is a labelled analogue of N-Descarboxymethyl-N-carboxyethyl Lacosamide (D289390). N-Descarboxymethyl-N-carboxyethyl Lacosamide is an impurity of Lacosamide (L098500), an anticonvulsant drug that enhances sodium channel slow inactivation, and is used to treat patients with epilepsy."
Synonyms
(2R)-3-Methoxy-2-[(1-oxopropyl)amino]-N-(phenylmethyl)propanamide
Application Notes
"N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 is a labelled analogue of N-Descarboxymethyl-N-carboxyethyl Lacosamide (D289390). N-Descarboxymethyl-N-carboxyethyl Lacosamide is an impurity of Lacosamide (L098500), an anticonvulsant drug that enhances sodium channel slow inactivation, and is used to treat patients with epilepsy."
References
"Doty, P., et al.: Neurotherapeutics, 4, 145 (2007); Perucca, E., et al.: Nat. Rev. Drug Discov., 7, 973 (2008); Sake, J., et al.: CNS Drugs, 24, 1055 (2010)"
